Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Endra Life Sciences Inc. (NDRA) since 2018 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Endra Life Sciences Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1681682.
Total stock buying since 2018: $306,720.
Total stock sales since 2018: $801,543.
Total stock option exercises since 2018: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 3,715 | $2,050 | 0 | $0 | 0 | $0 |
| 2023 | 98,333 | $124,749 | 0 | $0 | 0 | $0 |
| 2022 | 206,600 | $48,719 | 0 | $0 | 0 | $0 |
| 2021 | 0 | $0 | 118,750 | $163,370 | 0 | $0 |
| 2020 | 70,000 | $58,800 | 116,519 | $92,910 | 0 | $0 |
| 2019 | 60,000 | $72,402 | 0 | $0 | 0 | $0 |
| 2018 | 0 | $0 | 130,200 | $545,263 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-08 | 3,715 | $2,050 | 0 | $0 | 0 | $0 |
| 2023-05 | 98,333 | $124,749 | 0 | $0 | 0 | $0 |
| 2022-12 | 1,500 | $5,100 | 0 | $0 | 0 | $0 |
| 2022-11 | 10,000 | $1,700 | 0 | $0 | 0 | $0 |
| 2022-08 | 40,000 | $10,600 | 0 | $0 | 0 | $0 |
| 2022-05 | 155,100 | $31,319 | 0 | $0 | 0 | $0 |
| 2021-04 | 0 | $0 | 15,000 | $37,950 | 0 | $0 |
| 2021-03 | 0 | $0 | 18,750 | $44,437 | 0 | $0 |
| 2021-01 | 0 | $0 | 85,000 | $80,983 | 0 | $0 |
| 2020-12 | 0 | $0 | 96,519 | $77,610 | 0 | $0 |
| 2020-11 | 0 | $0 | 10,000 | $8,100 | 0 | $0 |
| 2020-10 | 0 | $0 | 10,000 | $7,200 | 0 | $0 |
| 2020-06 | 5,000 | $4,600 | 0 | $0 | 0 | $0 |
| 2020-05 | 65,000 | $54,200 | 0 | $0 | 0 | $0 |
| 2019-09 | 10,000 | $11,800 | 0 | $0 | 0 | $0 |
| 2019-08 | 10,000 | $15,550 | 0 | $0 | 0 | $0 |
| 2019-06 | 10,000 | $11,152 | 0 | $0 | 0 | $0 |
| 2019-05 | 30,000 | $33,900 | 0 | $0 | 0 | $0 |
| 2018-10 | 0 | $0 | 130,200 | $545,263 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-08-27 | Ubs Group Ag (10% Owner) | Buy | 3,715 | .55 | 2,050 |
| 2023-05-18 | Thornton Michael Milos (Chief Technology Officer) | Buy | 15,000 | 1.65 | 24,750 |
| 2023-05-02 | Digiandomenico Anthony (Director) | Buy | 83,333 | 1.20 | 99,999 |
| 2022-12-09 | Thornton Michael Milos (Chief Technology Officer) | Buy | 1,500 | 3.40 | 5,100 |
| 2022-11-23 | Tokman Alexander Y (Director) | Buy | 10,000 | .17 | 1,700 |
| 2022-08-22 | Thornton Michael Milos (Chief Technology Officer) | Buy | 20,000 | .27 | 5,400 |
| 2022-08-22 | Tokman Alexander Y (Director) | Buy | 20,000 | .26 | 5,200 |
| 2022-05-26 | Thornton Michael Milos (Chief Technology Officer) | Buy | 25,000 | .21 | 5,250 |
| 2022-05-18 | Thornton Michael Milos (Chief Technology Officer) | Buy | 25,000 | .22 | 5,500 |
| 2022-05-17 | Michelon Francois Roger (Chief Executive Officer) | Buy | 5,100 | .19 | 969 |
| 2022-05-16 | Tokman Alexander Y (Director) | Buy | 100,000 | .20 | 19,600 |
| 2021-04-07 | Thornton Michael Milos (Chief Technology Officer) | Sale | 15,000 | 2.53 | 37,950 |
| 2021-03-29 | Thornton Michael Milos (Chief Technology Officer) | Sale | 18,750 | 2.37 | 44,437 |
| 2021-01-13 | Maloberti Renaud Bertrand (Chief Commercial Officer) | Sale | 13,696 | 1.10 | 15,065 |
| 2021-01-12 | Maloberti Renaud Bertrand (Chief Commercial Officer) | Sale | 6,304 | 1.05 | 6,619 |
| 2021-01-08 | Maloberti Renaud Bertrand (Chief Commercial Officer) | Sale | 8,731 | .94 | 8,207 |
| 2021-01-08 | Tokman Alexander Y (Director) | Sale | 10,000 | .90 | 9,000 |
| 2021-01-06 | Maloberti Renaud Bertrand (Chief Commercial Officer) | Sale | 11,269 | .94 | 10,592 |
| 2021-01-06 | Wells David R. (Chief Financial Officer) | Sale | 34,900 | .90 | 31,410 |
| 2021-01-05 | Wells David R. (Chief Financial Officer) | Sale | 100 | .90 | 90 |
| 2020-12-17 | Maloberti Renaud Bertrand (Chief Commercial Officer) | Sale | 25,000 | .73 | 18,250 |
| 2020-12-04 | Michelon Francois Roger (Chief Executive Officer) | Sale | 71,519 | .83 | 59,360 |
| 2020-11-13 | Maloberti Renaud Bertrand (Chief Commercial Officer) | Sale | 10,000 | .81 | 8,100 |
| 2020-10-01 | Maloberti Renaud Bertrand (Chief Commercial Officer) | Sale | 10,000 | .72 | 7,200 |
| 2020-06-08 | Digiandomenico Anthony (Director) | Buy | 5,000 | .92 | 4,600 |
| 2020-05-29 | Basenese Lou (Director) | Buy | 10,000 | .90 | 9,000 |
| 2020-05-28 | Basenese Lou (Director) | Buy | 10,000 | .91 | 9,100 |
| 2020-05-28 | Digiandomenico Anthony (Director) | Buy | 5,000 | .90 | 4,500 |
| 2020-05-27 | Basenese Lou (Director) | Buy | 10,000 | .85 | 8,500 |
| 2020-05-26 | Basenese Lou (Director) | Buy | 10,000 | .82 | 8,200 |
| 2020-05-22 | Digiandomenico Anthony (Director) | Buy | 10,000 | .78 | 7,800 |
| 2020-05-21 | Basenese Lou (Director) | Buy | 10,000 | .71 | 7,100 |
| 2019-09-27 | Wells David R. (Chief Financial Officer) | Buy | 10,000 | 1.18 | 11,800 |
| 2019-08-23 | Wells David R. (Chief Financial Officer) | Buy | 5,000 | 1.55 | 7,750 |
| 2019-08-22 | Wells David R. (Chief Financial Officer) | Buy | 5,000 | 1.56 | 7,800 |
| 2019-06-10 | Harsh Michael (Director) | Buy | 500 | 1.14 | 570 |
| 2019-06-07 | Harsh Michael (Director) | Buy | 2,800 | 1.12 | 3,136 |
| 2019-06-06 | Harsh Michael (Director) | Buy | 6,600 | 1.11 | 7,326 |
| 2019-06-05 | Harsh Michael (Director) | Buy | 100 | 1.20 | 120 |
| 2019-05-16 | Thornton Michael Milos (Chief Technology Officer) | Buy | 30,000 | 1.13 | 33,900 |
| 2018-10-24 | Conrad Brett | Sale | 30,000 | 4.18 | 125,280 |
| 2018-10-23 | Conrad Brett | Sale | 50,000 | 4.22 | 210,900 |
| 2018-10-22 | Conrad Brett | Sale | 50,200 | 4.17 | 209,083 |
Insider trading activities including stock purchases, stock sales, and option exercises of NDRA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Endra Life Sciences Inc. (symbol NDRA, CIK number 1681682) see the Securities and Exchange Commission (SEC) website.